Helen M. Boudreau

Insider Reports History

Location
Charlotte, NC
Signature
/s/ David L. Klatsky, Attorney-in-fact
Transaction view
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Holdings reported by Helen M. Boudreau:

Form 4 holding Director

Cara Therapeutics, Inc.

Security class
Common Stock
Shares / value
150,647
Estimated value
$112,985
Report date
04 Jun 2024
Price
$0.7500
Ownership
Direct
Form 4 holding Director

Rallybio Corp

Security class
Option (Right to Buy)
Shares / value
16,500
Estimated value
$29,205
Report date
15 May 2024
Price
$1.77
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Cara Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
195,000
Estimated value
Report date
04 Jun 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Shattuck Labs, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
33,150
Estimated value
Report date
14 Jul 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Rallybio Corp

Security class
Option (Right to Buy)
Shares / value
28,500
Estimated value
Report date
13 May 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Helen M. Boudreau

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .